The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

Chikungunya, a mosquito-borne virus, has been detected at higher-than-expected rates among U.S. travelers from the Indian state. To reduce infection risk, the CDC urges travelers to adopt mosquito ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya ... of the CDC. Sign up here.